Target Prices for Mass Production of Tyrosine Kinase Inhibitors for Global Cancer Treatment
BMJ Open 6:e009586 doi:10.1136/bmjopen-2015-009586 Authors: Andrew Hill, Dzintars Gotham, Joseph Fortunak, Jonathan Meldrum, Isabelle Erbacher, Manuel Martin, Haitham Shoman, Jacob Levi, William G Powderly, Mark Bower. Objective: To calculate sustainable generic prices for 4 tyrosine kinase inhibitors (TKIs). Background: TKIs…
